메뉴 건너뛰기




Volumn 32, Issue 3, 1998, Pages 831-839

Advances in pharmaceutical market integration in mercosur and other Latin American countries

Author keywords

Economic integration; Latin America; MERCOSUR; Pharmaceutical markets; Regulatory harmonization

Indexed keywords

ARGENTINA; BRAZIL; DRUG MANUFACTURE; DRUG MARKETING; ECONOMICS; GOOD MANUFACTURING PRACTICE; PARAGUAY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARD; URUGUAY;

EID: 0031855335     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159803200323     Document Type: Review
Times cited : (3)

References (14)
  • 1
    • 3543010941 scopus 로고    scopus 로고
    • A bitter pill that offers scant relief
    • February 18
    • Woolacott M. "A bitter pill that offers scant relief." Guardian Weekly. February 18, 1996.
    • (1996) Guardian Weekly
    • Woolacott, M.1
  • 2
    • 3543018687 scopus 로고    scopus 로고
    • Second Thoughts on Globalization
    • February 26
    • Ogden C. "Second Thoughts on Globalization." Time. February 26, 1996.
    • (1996) Time
    • Ogden, C.1
  • 4
    • 33750133222 scopus 로고    scopus 로고
    • Buenos Aires, August 15
    • La Nación. Buenos Aires, August 15, 1996.
    • (1996) La Nación
  • 5
    • 3543032370 scopus 로고    scopus 로고
    • May 17
    • Scrip, No. 2129. May 17, 1996;20.
    • (1996) Scrip , vol.2129 , pp. 20
  • 6
    • 3543045739 scopus 로고
    • Geneva, Switzerland: World Health Assembly
    • Resolution WHA20.34. Geneva, Switzerland: World Health Assembly; 1967.
    • (1967) Resolution WHA20.34
  • 7
    • 3543043294 scopus 로고
    • Geneva, Switzerland: World Health Assembly
    • Resolution WHA22.50. Geneva, Switzerland: World Health Assembly; 1969.
    • (1969) Resolution WHA22.50
  • 8
    • 3543037161 scopus 로고
    • Geneva, Switzerland: World Health Assembly
    • Resolution WHA28.65. Geneva, Switzerland: World Health Assembly; 1975.
    • (1975) Resolution WHA28.65
  • 9
    • 0003494595 scopus 로고
    • Good manufacturing practices for pharmaceutical products
    • Annex 1. Thirty-second Report of the WHO Expert Committee on Specifications for Pharmaceutical Preparation. Geneva, Switzerland: World Health Organization
    • Good manufacturing practices for pharmaceutical products. Annex 1. Thirty-second Report of the WHO Expert Committee on Specifications for Pharmaceutical Preparation. WHO Technical Report Series N. 823. Geneva, Switzerland: World Health Organization; 1992.
    • (1992) WHO Technical Report Series N. 823 , vol.823
  • 11
    • 84993775093 scopus 로고
    • Interchangeable multi-source pharmaceutical products: WHO Draft Guideline on marketing authorization requirements
    • Geneva, Switzerland: World Health Organization
    • Interchangeable multi-source pharmaceutical products: WHO Draft Guideline on marketing authorization requirements. WHO Drug Information. Vol 8, No 2, 1994. Geneva, Switzerland: World Health Organization.
    • (1994) WHO Drug Information , vol.8 , Issue.2
  • 12
    • 3543038393 scopus 로고
    • Geneva, Switzerland; World Health Assembly
    • Resolution WHA41.18. Geneva, Switzerland; World Health Assembly; 1988.
    • (1988) Resolution WHA41.18
  • 13
    • 3543000662 scopus 로고
    • Geneva, Switzerland; World Health Assembly
    • Resolution WHA45.29. Geneva, Switzerland; World Health Assembly; 1992.
    • (1992) Resolution WHA45.29
  • 14
    • 3543034793 scopus 로고    scopus 로고
    • Gruntal & Co Outline; The Health Care & Medical Services Growth Trust; New York, NY: February 1996
    • Gruntal & Co Outline; The Health Care & Medical Services Growth Trust; New York, NY: February 1996.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.